W. Steube (R-FL)

Marijuana 1-to-3 Act of 2025

H.R. 4963 · House bill Crime and Law Enforcement

A Republican bill with 1 Democratic cosponsor · See all 3 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, titled the ``Marijuana 1-to-3 Act of 2025'', focuses on changing how marijuana is categorized under federal law. It directs the Attorney General of the United States to move marijuana from schedule I to schedule III of the Controlled Substances Act. This change must be completed through an order within 60 days after the act is passed. The bill specifically addresses the scheduling of marijuana as defined in the Controlled Substances Act.

Yes· 3 of 12

  • Scored +5

    Would business owners be better off under this?

    The bill significantly benefits business owners in the cannabis industry by easing federal drug scheduling restrictions.

  • Scored +5

    Does this shorten or soften prison sentences?

    The bill reduces the legal stigma and potential federal prosecution risks associated with marijuana by reclassifying it as a less restricted substance.

  • Scored +5

    Does this make health care easier to get in general?

    Rescheduling marijuana to schedule III recognizes its potential medical utility, which may facilitate easier access to medicinal use.

The opposite

  • Scored -2

    Does this give the federal government more power?

    The bill directs the Attorney General to execute a specific regulatory change, though it limits the severity of federal restrictions on the substance.